Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Quanta Services Inc (PWR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Quanta Services Inc — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.81 (market cap $8.88B), while Quanta Services Inc trades at $645 (market cap $99.31B). The key difference: Quanta Services Inc is far larger — about 11.2× Kymera Therapeutics Inc. Common Stock's market cap, and Quanta Services Inc pays a 0.07% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Quanta Services Inc for 62 Days on average.
| KYMR | PWR | |
|---|---|---|
Market Cap | $8.88B | $99.31B |
Volume | 1,028,790 | 1,067,966 |
Sector | Health | Industrials |
52-Week High | $127.31 | $785.24 |
52-Week Low | $55.80 | $412.21 |
Typical Hold Time | 0 Days | 62 Days |
Enterprise Value | $8.27B | $105.40B |
Dividend Yield | — | 0.07% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
PWR trades at $688.88, down 0.85% on the day, with a bullish technical outlook supported by moving averages and a strong $53B backlog. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results pending. Revenue growth is robust, rising from $17.1B in 2022 to $28.5B in 2025, though valuation multiples like a P/E of 78.82 are elevated. Analyst sentiment is overwhelmingly positive, with 27 buy ratings and a consensus price target of $802.08, implying significant upside.
The outlook for PWR is favorable, driven by infrastructure demand and AI-related data center investments, but risks include high valuation sensitivity, execution challenges from rapid growth, and macroeconomic pressures on capital spending. The stock's near-term performance will hinge on Q3 earnings delivery and margin sustainability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Quanta Services Inc
Quanta Services is a leading provider of specialty contracting services, delivering comprehensive infrastructure solutions for the electric and gas utility, communications, pipeline, and energy industries in the United States, Canada, and Australia. Quanta reports its results under two reportable segments: electric power infrastructure solutions and underground utility and infrastructure solutions. In October 2021, the company completed the acquisition of Blattner, a provider of comprehensive engineering, procurement, and construction solutions to customers in the renewable energy industry.
Read more on PWR →
